The importance of implementation of reliever-based regimens in adolescents and adults with asthma is emphasized in a commentary based on the Global Initiative for Asthma
“Biologics can reduce the burden of asthma exacerbations and [oral corticosteroids (OCS)] use in patients with asthma,” write authors of a Commentary on achieving clinical
“An impressive amount of progress has been made in identifying the molecular pathways that mediate type 2-high asthma, which has culminated in the introduction into
In the INSPIRE trial, avoidance of severe respiratory syncytial virus (RSV) infection in the first year of life of healthy, full-term infants was associated with
In the Mobility Asthma Project (MAP), children whose families were helped to move to better-resourced neighborhoods had lower rates of asthma morbidity, a study shows.
Health disparities make guideline-based and self-management of asthma “unattainable for most,” according to a workgroup of the American Association of Allergy and Clinical Immunology. “Given
The need for new therapies and adaptations in treating severe asthma with SARS-CoV-2 circulating and COVID-19 a common respiratory illness are discussed in a review
FDA last week approved ublituximab-xiiy (Briumvi, TG Therapeutics) for treating adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease,
Lancet: Challenges and Opportunities for Educating Health Professionals After the COVID-19 pandemic Diabetes Care: Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of